Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Automated Abdominal Binder for Orthostatic Hypotension in Autonomic Failure
NCT03482297Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Mar 2018
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in orthostatic hypotension (OH), pure autonomic failure (PAF) and multiple system atrophy (MSA) (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Orthostatic tolerance at 10 minutes and Orthostatic Hypotension Symptom Assessment at 10 minutes. Started Mar 2018; status: completed.
02
Conditions
orthostatic hypotension (OH)pure autonomic failure (PAF)multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT03482297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03482297.